Here are the 10-Q quarterly reports from The Estee Lauder Companies Inc. (EL) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow EL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EL filings page.
Estée Lauder Companies Inc. reported net sales of $3.715 billion for the three months ended September 30, 2026, versus $3.481 billion a year earlier. Net earnings were $233 million versus $47 million; diluted earnings per share were $0.64 versus $0.13. Operating income was $408 million, up from $169 million.
Operating activities used $166 million of cash, compared with $340 million used in the prior-year quarter. The company recorded $40 million in restructuring and other charges. It estimates a final net reduction of approximately 10,000 positions globally under its approved restructuring program; cumulative program charges were $1.475 billion through September 30, 2026, versus estimated total charges of approximately $1.7 billion before taxes.
On October 5, 2026, the company completed its purchase of the remaining 51% of Forest Essentials for $160 million, funded from cash on hand. It expects an approximately $94 million gain in fiscal 2027’s second quarter from remeasuring its prior 49% interest; a separate $37 million inducement payment will be recognized as operating expense in that quarter. On October 30, 2026, it declared a $0.35-per-share cash dividend payable December 15, 2026.
The Estée Lauder Companies Inc. reported higher sales and a return to profitability for the nine months ended March 31, 2026, while absorbing significant restructuring and legal costs. Net sales rose to $11.4 billion from $10.9 billion, and net earnings improved to $298 million from a prior-year loss of $587 million, yielding diluted EPS of $0.82.
Quarterly results were softer: March-quarter net sales were $3.7 billion versus $3.6 billion and net earnings were $89 million versus $159 million, with diluted EPS of $0.24. Operating income for the nine months reached $819 million versus a loss of $395 million last year, helped by lower impairment charges, but margins were pressured by $520 million of restructuring and other charges and an $84 million securities class action settlement expense.
The company expanded its Profit Recovery and Growth Plan, now expecting $1.5–$1.7 billion in restructuring and related charges and a net reduction of roughly 9,000–10,000 positions globally. Cumulative approved charges reached $1.42 billion and cumulative recorded charges were $1.13 billion. Cash flow from operations strengthened to $1.20 billion, supporting $381 million in dividends and $70 million of share repurchases while cash and cash equivalents increased to $3.13 billion.
The Estée Lauder Companies Inc. reported improved results for the quarter ended December 31, 2025, with net sales of $4,229 million and net earnings of $162 million, versus a loss of $590 million a year earlier. Sales rose across regions, led by Europe, the U.K. and Ireland and Emerging Markets at $1,183 million and Asia/Pacific at $900 million, while mainland China reached $928 million. Operating income swung to a $401 million profit from a $580 million loss as prior-year goodwill and trademark impairments did not recur. For the six-month period, net sales were $7,710 million and net earnings were $209 million, compared with a $746 million loss in the prior-year period.
The Estée Lauder Companies (EL) reported a return to profitability for the quarter ended September 30, 2025. Net sales were $3,481 million versus $3,361 million a year ago. Operating income reached $169 million compared with an operating loss of $121 million, and net earnings were $47 million, or $0.13 per diluted share, versus a loss of $156 million, or ($0.43) per share.
Cash flows used for operating activities were $340 million versus $670 million a year ago, and cash and cash equivalents were $2,219 million at quarter end. The effective tax rate was 56.9%, reflecting an estimated $8 million impact from newly enacted U.S. tax legislation. By region, sales were $1,174 million in the Americas, $901 million in Europe, UK & Ireland and Emerging Markets, and $873 million in Asia/Pacific, including $532 million in Mainland China. Under its Profit Recovery and Growth Plan, cumulative restructuring and other charges recorded reached $697 million as of September 30, 2025, with cumulative charges approved at $852 million through October 26, 2025; the program anticipates a net reduction of approximately 5,800 to 7,000 positions globally.